Search
Mark Minuti concentrates his practice in bankruptcy law. Having practiced bankruptcy law in Delaware since 1989, Mark has seen his practice grow from a small local practice to a sophisticated national practice. Along the way, Mark has been involved in almost every major bankruptcy case filed in...
The pharmaceutical industry faces a challenging business environment as competition drives down prices, R&D expenses rise, and government scrutiny deepens. However, companies have many options for navigating these challenges, generally by making deals with others in the field, including mergers and...
Michelle Streifthau-Livizos represents clients in litigation matters, including disputes involving the Hatch-Waxman Act, patents, copyrights and trademarks. She handles cases involving various types of technology, including representations of pharmaceutical companies, life sciences companies...
Sarah Sullivan represents pharmaceutical companies involved in complex, high stakes patent litigation. Sarah concentrates her practice on Hatch-Waxman ANDA cases and disputes over the intellectual property behind branded pharmaceuticals. She is part of the Firm's nationally-recognized team for...
Michelle G. Novick is an experienced insolvency professional with a reputation for thinking "outside the box" and finding practical, efficient solutions to clients' financial and legal problems. Michelle has represented clients on every side of a transaction in corporate bankruptcy proceedings. With...
Saul Ewing’s experienced patent attorneys assist companies and institutions in securing, leveraging, and enforcing commercially valuable intellectual property. From developing patent strategies on a global scale to vigorously asserting and defending patents in court, our team serves as trusted...
Stephen B. Ravin is a highly seasoned insolvency and bankruptcy attorney, with more than 40 years of experience. He has served as a fiduciary and fiduciaries' counsel throughout his career in both federal and state courts. He also has vast experience representing individual and corporate debtors...
Charlie Lizza brings more than 40 years of litigation experience to his representation of pharmaceutical companies in high stakes patent litigation. Mr. Lizza concentrates his practice in Hatch-Waxman ANDA litigation and protecting the intellectual property of branded pharmaceutical and medical...
Jeffrey Hampton is chair of the Bankruptcy and Restructuring Practice. He concentrates his practice on restructuring matters, including Chapter 11 bankruptcy proceedings, out-of-court workouts, loan restructurings, corporate reorganizations and general insolvency law. He also represents the...
George Apostolides is a business and bankruptcy litigator who advises clients in the life sciences, cannabis, higher education, manufacturing, retail and technology industries. Drawing on over 25 years of experience, George handles cases in federal and state courts both in Illinois and nationwide...
Alex Callo represents clients in high stakes intellectual property litigation, with a specific focus on complex pharmaceutical patent litigation under the Hatch-Waxman Act. His experience includes drafting motions and pleadings, research, and analyzing discovery. Alex has a background in both...
Bill Baton represents pharmaceutical companies in complex, often high-profile, patent litigation. Bill concentrates his practice in Hatch-Waxman ANDA litigation and protecting the intellectual property of branded pharmaceutical companies. He currently serves as New Jersey litigation counsel in more...
Luke Murley has substantial experience representing debtors, committees, acquirers, fiduciaries, and other significant parties in interest in complex reorganizations and financially distressed situations, both in and out of court. Luke regularly advises financially healthy businesses that find...
John Stoviak handles high-stakes litigation, complex trials and appeals for business, energy and environmental clients in courts throughout the United States, and he represents colleges, universities, and independent schools in delicate governance matters and issues. He has achieved two $100 million...